Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.
Katz
Odelia
O
Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Barzilay
Eran
E
Skaat
Alon
A
Herman
Amir
A
Mittelman
Moshe
M
Neumann
Drorit
D
D000818:Animals; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D015448:Leukemia, B-Cell / Q000188:drug therapy / Q000473:pathology; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010954:Plasmacytoma / Q000188:drug therapy / Q000473:pathology; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa